Basic Information
InkVivo Technologies AG is a Swiss biotechnology company spun off from ETH Zurich, dedicated to addressing a key challenge in drug development: improving drug formulation and delivery methods to enhance efficacy. Its proprietary polymer platform enables faster formulation optimization and more precise delivery of oral and long-acting injectable drugs.